Bryan Coburn Selected Research

Bryan Coburn Research Topics

Disease

8	Infections 11/2018 - 09/2004
7	Inflammation (Inflammations) 01/2022 - 06/2005
4	Neoplasms (Cancer) 01/2021 - 09/2019
3	Enterocolitis 02/2009 - 06/2005
2	Bacterial Vaginosis 01/2022 - 01/2022
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 06/2015
2	Bacteremia 01/2019 - 02/2018
2	Clostridium Infections 04/2018 - 02/2017
2	Critical Illness (Critically Ill) 02/2018 - 01/2018
2	Sepsis (Septicemia) 02/2018 - 01/2018
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	COVID-19 01/2021
1	Insulin Resistance 12/2019
1	Endotoxemia 12/2019
1	Body Weight (Weight, Body) 12/2019
1	Chronic Disease (Chronic Diseases) 12/2019
1	Obesity 12/2019
1	Fatty Liver 12/2019
1	Cystic Fibrosis (Mucoviscidosis) 05/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Persistent Infection 12/2018
1	Bacterial Infections (Bacterial Infection) 02/2018
1	Coinfection 02/2018
1	Superinfection 01/2017
1	Communicable Diseases (Infectious Diseases) 06/2015
1	Colitis 02/2009
1	Diarrhea 04/2008
1	Foodborne Diseases 04/2008
1	Gastroenteritis 04/2008
1	Typhoid Fever (Typhoid) 09/2004

Drug/Important Bio-Agent (IBA)

7	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 02/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	CytokinesIBA 01/2022 - 02/2009
2	Metronidazole (Metric)FDA LinkGeneric 01/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2019
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2019 - 04/2013
1	ChemokinesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Indigo Carmine (Indigo Blue)IBA 12/2019
1	Insulin (Novolin)FDA Link 12/2019
1	Interleukin-22 (IL-22)IBA 12/2019
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2019
1	Interleukin-10 (Interleukin 10)IBA 12/2019
1	LigandsIBA 12/2019
1	CefsulodinIBA 05/2019
1	Cefepime (Maxipime)FDA LinkGeneric 05/2019
1	Meropenem (Merrem)FDA LinkGeneric 05/2019
1	Aztreonam FDA LinkGeneric 05/2019
1	Ceftazidime (Fortum)FDA LinkGeneric 05/2019
1	LactamsIBA 05/2019
1	Piperacillin FDA LinkGeneric 05/2019
1	Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA 05/2019
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2019
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	FluoroquinolonesIBA 01/2019
1	AminoglycosidesIBA 01/2019
1	Tobramycin (Nebcin)FDA LinkGeneric 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	beta-Aminoethyl Isothiourea (AET)IBA 11/2018
1	SolutionsIBA 11/2018
1	boldenone undecylenate (Equipoise)IBA 02/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Vancomycin FDA LinkGeneric 02/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Levofloxacin (Levaquin)FDA Link 04/2013
1	Chemokine CCL3IBA 02/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2009
1	Streptomycin (Streptomycin Sulfate)FDA Link 02/2009
1	lambda Spi-1IBA 04/2008
1	Type III Secretion SystemsIBA 06/2005
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2005
1	CationsIBA 09/2004
1	MetalsIBA 09/2004

Therapy/Procedure

11	Therapeutics 01/2022 - 04/2013
2	Immunotherapy 10/2020 - 09/2019
2	Fecal Microbiota Transplantation 04/2018 - 02/2017
2	Duration of Therapy 02/2018 - 06/2015
1	Intravaginal Administration 01/2022
1	Chemoradiotherapy 01/2021
1	Subcutaneous Injections 01/2021
1	Vascular Access Devices (Arterial Line) 02/2018
1	Artificial Respiration (Mechanical Ventilation) 02/2018
1	Long-Term Care 06/2015